About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Illinois | 25,059 Studies Near You

Clinical TrialsIllinois

Clinical Trials in Illinois

Discover 25,059 clinical trials near Illinois. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 2641-2660 of 25,059 trials

CompletedA Study to Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and InfluenzaSubstudy A: This is a Phase 1 randomized, open-label study to describe the safety and immunogenicity of up to 3 dose- level combinations of modRNA quadrivalent influenza vaccine…NCT05596734·Athens, Alabama and 58 others

Find Trials by Condition in Illinois

Breast Cancerin Illinois Lung Cancerin Illinois Prostate Cancerin Illinois Colorectal Cancerin Illinois Melanomain Illinois Leukemiain Illinois Lymphomain Illinois Pancreatic Cancerin Illinois Ovarian Cancerin Illinois Brain Cancerin Illinois Diabetes

Data from ClinicalTrials.govTerms

Active not recruitingStudy Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)This is a Phase 1/2, open-label, multicenter study to determine the efficacy and safety of JCAR017 in adult subjects with relapsed or refractory CLL or SLL.NCT03331198·Birmingham, Alabama and 83 others

CompletedThe Efficacy, Safety, and Tolerability of Laquinimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)This is a multinational, multicenter, randomized, double-blind, parallel-group, placebo-controlled study followed by active treatment, to evaluate the efficacy, safety and…NCT01707992·Cullman, Alabama and 283 others

CompletedVerTouch Device: A Prospective Randomized Controlled TrialThis study will compare the VerTouch device to palpation and ultrasound (US) techniques used to identifying the anatomic landmarks and optimal location for neuraxial access.NCT04630171·Chicago, Illinois

CompletedStudy of Safety, Efficacy of Fulranumab Adjunctive Use in OA of Hip or Knee, PAI3007The purpose of this study is to demonstrate the efficacy, safety, and tolerability of fulranumab as adjunctive therapy compared with placebo in participants with signs and…NCT02301234·Glendale, Arizona and 63 others

CompletedEffect of Azithromycin on Lung Function in 6-18 Year-olds With Cystic Fibrosis (CF) Not Infected With P. AeruginosaThis is a study to examine the safety, effect on lung function, and frequency of symptoms relating to cystic fibrosis during 24 weeks of treatment with the antibiotic azithromycin…NCT00431964·Phoenix, Arizona and 39 others

RecruitingNorthwestern Neuromuscular Disease BiorepositoryThe primary objective of this research is to collect clinical data and tissue samples from adult patients with neuromuscular disease cared for at the Northwestern Memorial…NCT07477509·Chicago, Illinois

CompletedTrial of VELCADE and Rituxan as Front-line Tx for Low-grade NHLBortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the cancer.NCT00369707·Miami, Florida and 3 others

Completed3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining StudyA dose defining study of the protease inhibitor tipranavir (TPV), boosted with low dose ritonavir (RTV).NCT00275444·Phoenix, Arizona and 61 others

CompletedRadiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal CancerRATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells and shrink tumors.NCT01302834·Anchorage, Alaska and 184 others

Active not recruitingWATER IV Prostate CancerThis is a multicenter, prospective, randomized clinical trial that aims to assess the safety and efficacy of Aquablation Therapy in men with low-risk to intermediate to high-risk…NCT06651632·Chandler, Arizona and 36 others

Completed"A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA"This is a Phase 3 study to assess the long-term safety and maintenance of efficacy of JZP-110 in subjects who have completed Study 14-002, 14-003, 14-004, 15-004, 15-005, ADX-N05…NCT02348632·Birmingham, Alabama and 79 others

CompletedA Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney DiseaseResearchers are looking for a better way to treat people who have non-diabetic chronic kidney disease (non-diabetic CKD).NCT05047263·Huntsville, Alabama and 325 others

CompletedS0410 Tandem Stem Cell Transplantation in Treating Patients With Progressive or Recurrent Hodgkin's LymphomaRATIONALE: Radiation therapy uses high-energy x-rays to kill cancer cells.NCT00233987·Sacramento, California and 52 others

TerminatedA Study of Tivozanib in Combination With Durvalumab in Subjects With Advanced Hepatocellular CarcinomaThis study will evaluate the safety, tolerability, DLTs, MTD, and preliminary anti tumor activity of tivozanib in combination with durvalumab in subjects with advanced HCC.NCT03970616·Gilbert, Arizona and 9 others

CompletedSafety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative ColitisThis study is a prospective clinical study to evaluate the safety and efficacy of two different doses of Asacol for the treatment of moderately active ulcerative colitis.NCT00073021·Scottsdale, Arizona and 56 others

RecruitingStudy Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid TumorsHWK-007-101 is a multicenter, open-label, first-in-human (FIH) Phase 1 study evaluating HWK-007, a protein tyrosine kinase 7 (PTK7)-targeted antibody drug conjugate (ADC), in…NCT07444814·Little Rock, Arkansas and 11 others

CompletedGenetic Predisposition-Chronic Nephrotoxicity From CI-Liver Transplant Recipients-Potential Correlation-Urinary BiomarkersThe purpose of this study is to determine the relationship between genomic variants of components of the renin-angiotensin system and the development of kidney problems due to…NCT00857844·Chicago, Illinois

CompletedGenetic Studies of Inflammatory Bowel DiseaseThis study will examine the existence of genetic regions that are believed to bring about a risk for inflammatory bowel disease (IBD), with its subtypes of Crohn's disease and…NCT00340444·Chicago, Illinois and 4 others

UnknownMonoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and ChemotherapyRATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells.NCT00003634·Berkeley, California and 45 others

PreviousPage 133 of 1253Next

in Illinois

Heart Diseasein Illinois